2m 2m 2m 2m 2m 2m 2m
PASITHEA THERAP (KTTA)
NASDAQ
$0.44-$0.006 (-1.39%)
Price as of Oct 22, 2026 7:54 PM EDT- $16.3MMarket Cap
- -32.17%1-Year Change
- BiotechnologyIndustry
PASITHEA THERAP (KTTA)
$0.44-$0.006 (-1.39%)
KTTA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.45 | ||
Change | +$0.08 (+18.98%) | ||
Open | $0.49 | ||
High | $0.50 | ||
Low | $0.45 | ||
Previous Close | $0.49 | ||
Volume | 379,120 | ||
30-Day Average Volume | 139,115 | ||
1-Week Change | 19.15% | ||
1-Month Change | -4.43% | ||
1-Year Change | -32.17% | ||
3-Year Change | -94.81% | ||
5-Year Change | -99.09% | ||
Fundamentals | |||
Shares Outstanding | 33.4M | ||
Total Assets | $51.7M | ||
Market Cap | $16.3M | ||
Enterprise Value | -$29.4M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$5.3M | ||
Free Cash Flow | -$4.7M | ||
EBIT | -$5.3M | ||
EBITDA | -$5.1M | ||
Net Working Capital | $46.4M | ||
EPS | -$0.16 | ||
Enterprise Value/EBITDA | 6 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 0 | ||
P/E | -3 | ||
PEG | 0 | ||
Price/Free Cash Flow | -3 | ||
Price/Operating Cash Flow | -3 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 01/02/2024 | ||
Earnings & Revenue